Racial Differences in Prevalence of Coronary Obstructions Among Men With Positive Nuclear Imaging Studies  by Whittle, Jeff et al.
R
o
M
J
M
L
M
K
A
o
i
r
l
s
t
s
h
r
i
M
M
Q
M
H
S
U
Q
M
D
r
A
N
R
D
Journal of the American College of Cardiology Vol. 47, No. 10, 2006
© 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00
Pacial Differences in Prevalence
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OBJECTIVES The purpose of this research was to compare coronary obstruction between clinically similar
African Americans (AA) and white persons undergoing coronary angiography.
BACKGROUND African Americans have higher rates of coronary death than whites, but are less likely to
undergo coronary revascularization. Although differences in coronary anatomy do not explain
racial difference in revascularization rates, several studies of clinically diverse persons
undergoing coronary angiography have found less obstructive coronary disease in AA than
clinically similar whites.
METHODS We studied 52 AA and 259 white male veterans who had both a positive nuclear perfusion
imaging study and coronary angiography within 90 days of that study in five Department of
Veterans Affairs hospitals. We used chart review and patient interview to collect demograph-
ics, clinical characteristics, and coronary anatomy results. Before angiography, we asked
physicians to estimate the likelihood of coronary obstruction.
RESULTS The treating physicians’ estimates of coronary disease likelihood were similar for AA (79.5%)
and whites (83.0%); AA were less likely to have any coronary obstruction (63.5% vs. 76.5%,
p  0.05) and had significantly less severe coronary disease (p  0.01) than whites. African
Americans continued to be less likely to have coronary obstruction in analyses controlling for
clinical features, including the physician’s estimate of the likelihood of coronary obstruction.
CONCLUSIONS These results suggest that AA have less coronary obstruction than apparently clinically similar
whites. Further studies are required to confirm our findings and better understand the paradox
that AA are less likely to have obstructive coronary disease and more likely to suffer mortality
from coronary disease. (J Am Coll Cardiol 2006;47:2034–41) © 2006 by the American
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.059College of Cardiology Foundation
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nfrican Americans (AA) are more likely than whites to die
f cardiovascular disease, the most common cause of death
n both AA and whites (1). The racial difference in mortality
ates is especially striking among individuals with estab-
ished coronary artery disease (CAD). Because in several
ettings coronary revascularization increases survival in pa-
ients with established coronary disease (2,3), it has been a
urprising paradox that AA have repeatedly been shown to
ave lower rates of coronary angiography and coronary
evascularization than whites (4–9). This disparity is present
n Department of Veterans Affairs (VA) as well as private
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epartment of Veterans Affairs, Health Services Research and Development Service 2ector hospitals and persists after adjustment for clinical
actors (10,11). These lower rates of revascularization have
een associated with lower rates of survival after diagnosis,
djusting for other clinical variables (12).
This difference in revascularization rates may be related in
art to the finding that in several settings AA undergoing
oronary angiography have been less likely than whites to
ave severe coronary disease, defined as significant obstruc-
ions in the distribution of all three major coronary vessels or
he left main coronary artery (13–15). Moreover, AA who
ave acute ischemia and undergo coronary angiography are
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May 16, 2006:2034–41 Coronary Anatomy and Raceore likely than whites to be found to have no obstructive
esions (16). Because there are also racial differences in rates
f coronary angiography (4,17), it is possible this is due to
election bias. However, at least one population-based study
sing electron beam computed tomography found that
oronary artery calcium scores, which are a marker for
oronary atherosclerosis, are lower in AA than in age- and
ender-matched whites (18). This is true both among
ersons with established cardiovascular disease and among
hose with no known cardiovascular disease.
These observations suggest there may be important dif-
erences in the prevalence of coronary obstruction among
linically apparently similar AA and white populations. If
rue, there might be important implications for diagnostic
valuation and treatment in these settings. For example, the
AND criteria for appropriateness of coronary revascular-
zation heavily emphasize the presence and number of
oronary artery stenoses of at least 70% (19). Indeed, in our
rior work using clinically detailed data for other patient
opulations, adjustment for the presence of stenoses has
educed but not eliminated the magnitude of racial dispar-
ties in revascularization rates (10,11). Therefore, we carried
ut the present analysis of patients participating in the
ardiac Decision Making Study (CDMS) (17). In the
DMS, coronary angiography rates were significantly
igher in white (47%) than AA (33%) patients. This
ifference persisted after adjustment for clinical factors. We
anted to determine whether there are differences in coro-
ary anatomy between white and AA patients who received
oronary angiography because of the results of non-invasive
esting.
ETHODS
tudy population. The CDMS is an observational cohort
tudy of self-identified white or AA veterans who under-
ent non-invasive testing for coronary obstructive disease at
ne of five participating VA medical centers between
ugust 1999 and January 2001. Study personnel attempted
o enroll all veterans who had a nuclear imaging study that
uggested coronary ischemia, according to the local inter-
reter. These studies were performed as part of routine
linical care. Thus, they included a variety of techniques
resting and delayed, various exercise protocols, and various
harmacological stressors) and radionuclides (e.g., single
nd dual isotope) in keeping with local practice patterns.
etails of the recruitment process have been published,
Abbreviations and Acronyms
AA  African Americans
CAD  coronary artery disease
CDMS  Cardiac Decision Making Study
SAQ  Seattle Angina Questionnaire
VA  Department of Veterans Affairs17,20), but we present a brief summary. oWe screened 5,278 patients who had a nuclear imaging
tudy, of whom 2,335 (44%) had a positive study. Of these,
e excluded 981 for the following reasons: 456 patients
19%) could not be contacted to enroll in the study; 209
9%) had had a cardiac procedure in the preceding six
onths; 102 (4%) were not AA or white; 78 (3%) had
mpaired mental status; 32 (1%) were in another research
tudy determining their cardiac treatment; and 104 (4%)
ere excluded for miscellaneous other reasons (e.g., the
uclear imaging study was conducted for a compensation
nd pension evaluation, the patient’s hearing was impaired,
r the patient was not a veteran). Of the remaining 1,354
atients with positive imaging studies, 329 overtly refused,
ailed to return their informed consent, or failed to return
ailed questionnaires. Thus, 1,025 (75.7%) persons of
,354 eligible veterans who were contacted agreed to par-
icipate. For the present analysis, we restricted our attention
o those veterans (n  318) who had coronary angiography
ithin 90 days after their imaging study. We dropped all
omen (n  7) from the analysis, because all were white,
otentially confounding our racial comparison.
ata. We reviewed the medical records of each study
espondent, obtaining records for non-VA care where pos-
ible. Trained nurses who were blinded to both study aims
nd the race of the patient abstracted patient demographics,
ardiac symptoms, and past medical history (including prior
yocardial infarction or prior coronary revascularization,
ngina, congestive heart failure, diabetes, hypertension,
enal dysfunction, or chronic obstructive lung disease). The
bstractors used the official coronary angiogram report to
etermine the presence of obstruction in each of the major
oronary systems, and whether there was obstruction of the
roximal left anterior descending artery. As an indication of
he extent to which medical therapy had been maximized
or each patient, we used the American College of Cardi-
logy/American Heart Association guidelines for coronary
ngiography and the management of patients with chronic
table angina (21,22). Thus, we defined maximal medical
herapy as antiplatelet therapy, sublingual nitroglycerin, and
t least one of the following: beta-blockers, calcium-channel
lockers, or long-acting nitrates.
We used patient responses to the Seattle Angina Ques-
ionnaire (SAQ) to assess patients’ perceptions of anginal
tability and frequency (23). To assess the physician’s
erception of the probability of the patient having CAD, we
sked, “On a scale from 0% to 100%, please estimate the
robability of CAD in this patient (70% or more narrowing
f an epicardial artery).”
We classified coronary obstruction as severe if either the
eft main coronary artery or all three major coronary systems
ad a stenosis of 70% or greater. We classified non-severe
bstructions as moderate if the proximal left anterior de-
cending artery was involved, and mild if it was not, but if
here was at least one coronary obstruction of 70%. We
lassified coronary obstruction as none if there was no
bstruction of 70% (16).
a
e
r
r
a
m
w
d
a
h
t
s
c
b
o
D
(
r
t
t
p
m
d
u
w
s
p
m
a
r
r
i
k
c
d
l
n
n
u
s
S
t
t
a
u
d
c
w
(
i
e
r
s
m
s
m
l
r
d
s
p
r
s
r
a
t
a
B
s
s
p
r
b
v
w
a
m
s
R
O
h
i
F
w
s
l
w
m
A
h
m
A
w
t
m
2
o
s
o
c
o
s
p
2036 Whittle et al. JACC Vol. 47, No. 10, 2006
Coronary Anatomy and Race May 16, 2006:2034–41Two physicians, a board-certified general internist (J.W.)
nd a cardiology fellow (M.M.), classified the severity of
ach nuclear imaging study based on review of the official
eport, which did not include information about patient
ace. We categorized the risk of severe coronary obstruction
s low, moderate, or high, using a modification of the
ethods of Bateman et al. (24). In this method, patients
ith reversible lesions in the distribution of left anterior
escending coronary artery or in both the right coronary
rtery and left circumflex artery were considered to be at
igh risk, as were patients with increased lung uptake or
ransient ischemic dilation with exercise or pharmacologic
tress. Patients with reversible lesions in just one of the right
oronary artery or left circumflex artery were considered to
e at moderate risk. Patients whose defects were very small
r minimally reversible were considered to be at low risk.
isagreements were resolved by consensus.
We considered the use of more complex scoring systems
25–27). However, these methods require data elements not
outinely included in the reports generated at one or more of
he five sites participating in the present study. For example,
he method of Hachamovitch et al. (25) considers the
ercent of myocardium that has fixed defects, the percent of
yocardium that has reversible defects, and the presence of
yspnea as a presenting symptom, none of which were
niformly available to us. More importantly, these systems
ere primarily developed to predict coronary disease events
uch as myocardial infarction or death, not to predict the
resence of significant obstructions. In contrast, the Bate-
an system, although not a validated prognostic method, is
n established predictor of coronary angiography (24), and
elies solely on the distribution and qualitative severity of
eversible defects, along with the presence of transient
schemic dilation or increased lung uptake, each of which is
nown to be correlated with the presence and severity of
oronary obstruction (27). Our study is motivated by our
esire to understand racial differences in coronary revascu-
arization rates. Because methods to assess the appropriate-
ess of revascularization are heavily dependent on the
umber and location of coronary stenosis (19), we elected to
se the Bateman approach, rather than one of the more
ophisticated predictors of prognosis.
tatistical analysis. We first examined the bivariate rela-
ionship of race to coronary obstruction using a chi-square
est for trend. We then dichotomized coronary obstruction
s any versus no obstructive disease for further analyses. We
sed t tests or chi-square tests as appropriate to compare this
ichotomous variable to each of the potential confounders.
To determine the relationship of race to the presence of
oronary obstruction controlling for confounding factors,
e used logistic regression modeling. We used stepwise
i.e., both forward and backward) selection as implemented
n SAS to select variables from among potential confound-
rs, including age, comorbid conditions, previous coronary
evascularization, previous myocardial infarction, angina
tability and frequency, whether the patient was on maximal aedical therapy, and the results of the nuclear imaging
tudy. We used a p value of 0.10 for variables to enter the
odel, and a p value of 0.10 to remove variables that no
onger contributed to the model. This approach tends to
etain control variables of marginal significance, which
ecreases bias in our estimate of the effect of race, with a
mall cost in increased variance. In our stepwise selection
rocedure, we forced race and site of care into the model,
egardless of their level of significance. Although we treat
ite as a fixed effect during model selection, our final logistic
egression model treats site of care as a random effect to
ccount for the site cluster effect such that patients within
he same site might share similar characteristics that are
ssociated with the presence of coronary obstruction (28).
ecause the physician’s global estimate of the likelihood of
ignificant coronary obstruction presumably took into con-
ideration many of the other factors in the model, we
resent models with and without this variable. To check the
obustness of our stepwise procedure, we also performed a
ackward selection algorithm with a p value of 0.10 for
ariables to be retained in the model.
All analyses were conducted using SAS statistical soft-
are (SAS Inc., Cary, North Carolina). This study was
pproved by the human studies subcommittee of the VA
edical centers where data collection took place, and by the
tudy coordinating center.
ESULTS
f the 1,025 participants in the CDMS, 311 men (30.3%)
ad coronary angiography within 90 days of the nuclear
maging study and are included in the present analysis.
ifty-two (16.7%) were AA. Characteristics of AA and
hite participants are compared in Table 1. We observed
everal non-significant trends—whites were older and more
ikely to have had a previous revascularization, while AA
ere somewhat more likely to have angina reported in the
edical record, or to be on maximal medical therapy.
frican Americans were significantly more likely to have
ypertension (92.3% vs. 79.5%, p  0.03). Physician esti-
ates of the likelihood of CAD were similar in whites and
A (mean of 83.0% vs. 79.5%, p  0.25).
In bivariate analyses, AA had less severe CAD than
hites (Fig. 1) (p  0.01). In particular, AA were less likely
o have severe obstructive disease (39.4% vs. 26.9%) and
ore likely to have no significant obstructions (36.5% vs.
3.6%).
The rest of the bivariate results (Table 2) treat coronary
bstruction as a dichotomous variable—either at least one
ignificant obstruction is present, or there are no significant
bstructions. The proportion of patients with CAD in-
reased stepwise with age, from 67.9% of patients55 years
ld to 80.5% of those 65 years old. The likelihood of a
ignificant obstruction was also greater among patients with
rior myocardial infarction or prior revascularization, as well
s among patients on maximal medical therapy. No comor-
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May 16, 2006:2034–41 Coronary Anatomy and Raceid condition was associated with the presence of CAD.
eattle Angina Questionnaire scores were similar in patients
ith and without coronary disease for both stability (SAQ
tability score 64.3 vs. 64.9, p  0.90) and frequency (SAQ
requency score 68.4 vs. 73.4, p 0.18). Physician estimates
f the likelihood of obstructive coronary disease were higher
n patients who had at least one obstructive lesion (mean of
5.2% vs. 73.7%, p  0.0002). This was true among AA
mean of 83.2% vs. 74.4%, p  0.12) and white (mean of
5.5% vs. 73.4%, p  0.0011) patients.
able 1. Characteristics of Study Patients by Race
Percent With
Characteristic
Patient Characteristics White AA p Value
ge (mean, SD) 62.8, 9.6 59.9, 10.9 0.06
ge 20–54 yrs 24.3 34.6
ge 55–64 yrs 32.1 26.9 0.30
ge 65 yrs or older 43.6 38.5
ite of care A 16.6 13.5
ite of care B 19.7 30.8
ite of care C 18.5 34.6 0.002
ite of care D 27.4 5.8
ite of care E 17.8 15.4
rior myocardial infarction 38.0 33.3 0.53
rior revascularization 35.4 25.0 0.15
aximal medical therapy 39.4 50.0 0.16
ngina on chart review 72.3 82.7 0.12
ypertension 79.5 92.3 0.03
iabetes mellitus 30.1 26.9 0.65
enal dysfunction 12.0 17.3 0.29
ongestive heart failure 20.2 21.2 0.88
hronic obstructive lung disease 25.1 19.6 0.40
uclear study, high risk 55.8 50.0
uclear study, moderate risk 37.5 44.2 0.66
uclear study, low risk 6.8 5.8
AQ frequency score 70.5 65.6 0.26
AQ stability score 65.4 59.8 0.28
hysician estimated likelihood
of obstructive coronary
disease (%)
83.0 79.5 0.25
A  African American; SAQ  Seattle Angina Questionnaire, scale is 0–100,
here lower numbers mean more frequent or less stable angina.
igure 1. Relationship of race to severity of coronary artery disease. The
istribution of the severity of coronary artery disease is significantly different
etween African Americans (AA) (solid bars) and whites (open bars), p 
.01, by Mantel-Haenszel chi-square test for trend: Severe  left main or all
hree coronary artery systems with significant obstructions; Moderate one or
wo systems with obstructions, including the proximal left anterior descending;a
ild  one or two systems with obstructions, not including the proximal left
nterior descending; None  no obstruction 70%.In multivariate analyses (Table 3), race, prior revascular-
zation, and the physician’s estimate of the likelihood of
AD were all significantly associated with coronary ob-
truction at the p  0.05 level. The white to AA odds ratio
or having at least one significant obstruction was 2.77 (95%
onfidence interval 1.29 to 5.93, p  0.009). Because
hysician global estimate of the likelihood of coronary
isease presumably incorporates many of the clinical vari-
bles, we repeated the analysis omitting that variable. In this
nalysis previous myocardial infarction and the severity of
he defect on nuclear imaging were significantly associated
ith having obstructive disease, as was prior revasculariza-
ion. The white-to-AA odds ratio for having at least one
ignificant obstruction was 2.21 (95% confidence interval
.10 to 4.48, p  0.028). In both models, study site
ccounted for significant variation.
ISCUSSION
e found that whites had more severe coronary disease
han AA in this population of male veterans with evidence
f ischemia on nuclear imaging. In multivariate analysis,
A were less likely to have at least one significant coronary
able 2. Presence of at Least One Coronary Obstruction by
atient Characteristics
Patient Characteristics n
Percent
With Any
Obstruction p Value
hite 259 76.5 0.05
frican American 52 63.5
ge 20–54 yrs 81 67.9
ge 55–64 yrs 97 71.1 0.03*
ge 65 yrs or older 133 80.5
ite of care A 49 54.0
ite of care B 67 91.0
ite of care C 65 65.2 0.0001
ite of care D 72 70.3
ite of care E 54 88.9
rior myocardial infarction 114 87.7 0.0001
o prior myocardial infarction 192 66.7
rior revascularization 104 85.6 0.0014
o prior revascularization 205 68.8
aximal medical therapy 128 80.5 0.0367
ot on maximal medical therapy 183 70.0
ngina by chart review 228 75.0 0.6595
o angina on chart review 80 72.5
ypertension 253 75.5 0.4052
o hypertension 57 70.2
iabetes mellitus 92 70.7 0.3433
o diabetes mellitus 219 75.8
enal dysfunction 40 75.0 0.9107
o renal dysfunction 271 74.2
ongestive heart failure 63 76.2 0.7691
o congestive heart failure 246 74.4
hronic obstructive lung disease 75 74.7 0.9144
o chronic obstructive lung disease 235 74.0
uclear study, high risk 166 77.1
uclear study, moderate risk 117 71.8 0.09*
uclear study, low risk 20 60.0
Mantel-Haenszel chi-square test for trend.rtery obstruction, controlling for demographic and clinical
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Coronary Anatomy and Race May 16, 2006:2034–41ariables, physician estimates of the likelihood of CAD, and
ite of care. These results add to the growing body of
iterature that suggests that despite less frequent use of
oronary angiography among AA patients, those AA who
ndergo the procedure are actually at lower risk for having
oronary obstructive disease than whites who undergo the
rocedure.
There is a substantial literature demonstrating less ob-
tructive coronary disease in AA than among whites drawn
rom populations undergoing coronary angiography. In an
nalysis of the Coronary Artery Surgery Study database,
aynard et al. (13) reported that blacks were more likely
han whites to have no significant stenoses, and that whites
ere more likely to have severe disease (i.e., involvement of
he left main or parts of all three major epicardial vessels).
imilarly, in a study of 6,594 patients undergoing coronary
ngiography at a single center, Oberman and Cutter (14)
ound whites more often had multivessel disease than AA.
n a multicenter study of patients presenting to emergency
epartments for chest pain, Johnson et al. (15) found that
5% of AA who underwent coronary angiography had no
ignificant coronary obstructions compared with just 16% of
hites who had the procedure. Although large, each of
hese studies had limited clinical detail and persons were
ndergoing coronary angiography for a variety of indica-
ions. A more recent study limited to persons undergoing
oronary angiography during an admission for an acute
oronary syndrome (myocardial infarction or unstable an-
ina) had similar results (16). In that study, 19% of AA and
% of whites admitted for acute myocardial infarction had
o coronary artery obstruction of 70% or greater. In the
ame study, 33% of AA and 17% of whites with unstable
ngina had no such obstructions. Moreover, these differ-
nces persisted after controlling for a variety of clinical
ariables obtained from chart review. These findings from
ngiographic studies in clinical populations are reinforced by
ndings reported by Newman et al. (18) in a population-
ased study of Medicare beneficiaries participating in the
Table 3. Multivariable Odds Ratios for Having
Coronary Angiography, Adjusted for Site of C
With Physicia
Estimate of
Characteristics Odds Ratio 95%
White race 2.77 1.29–5
Prior revascularization 4.39 1.88–1
Prior myocardial infarction — —
Imaging defect severity†
Mild — —
Moderate
Physician estimated risk‡ 1.30 1.11–1
*Candidate variables for the modeling included age, com
myocardial infarction, angina stability, and frequency, wheth
the nuclear imaging study; †severity of imaging defect doe
included; ‡Odds ratio represents the effect of a 10% increase
at least one coronary obstructive lesion 70%.
CI  confidence interval.ardiovascular Health Study. They found that, after con- rrolling for standard atherosclerotic risk factors, older AA
ad less coronary artery calcium (a marker for coronary
bstructive disease) than similar whites, both in the presence
nd absence of clinical coronary disease (18).
Our study goes beyond these previous studies by adding a
tandardized assessment of the patients’ anginal symptoms
nd the physician’s assessment of the likelihood of CAD to
he clinical data available on chart review. Because this
hysician assessment added importantly to the model, we
elieve it is a particularly valuable contribution of the
resent study.
Although the present study was a prospective study of
atients with a similar course to angiography and used a
ide variety of data sources to gain a comprehensive clinical
icture, it had a number of limitations. First, not all patients
ith a positive imaging study underwent coronary angiog-
aphy. Thus, it is possible that physicians are simply less able
o select AA patients at high risk for coronary disease, either
ecause the diagnostic tests in use are less accurate in this
opulation, or because cross-cultural communication differ-
nces make it harder to interpret the clinical history that is
he cornerstone of clinical decision making (29,30). Alter-
atively, physicians may utilize the epidemiologic evidence
egarding higher death rates among AA with CAD and may
hus use lower thresholds to refer them to angiography.
owever, this trend was not seen in a study in which
rimary care physicians viewed videotapes of actors that
ortrayed identical clinical stories. In that study, Schulman
t al. (31) found the physicians were less likely to refer black
omen for coronary angiography than black or white men
r white women. Moreover, in the present study, AA were
ess likely to undergo coronary angiography than whites,
ven after controlling for clinical differences (17). Despite
his, we must acknowledge that there may be important,
hough unidentified, factors that influence whether AA
atients undergo coronary angiography.
Second, because this was a study of actual practice, the
linicians who provided this care were aware of the patients’
east One 70% or Greater Stenosis on
bal Without Physician Global
Estimate of Risk
p Value Odds Ratio 95% CI p Value
0.009 2.21 1.10–4.48 0.028
0.0007 2.21 1.12–4.34 0.023
— 1.96 1.00–3.87 0.053
— 0.28 0.10–0.80 0.018
0.61 0.34–1.10 0.10
0.0015 — — —
conditions, previous coronary revascularization, previous
patient was on maximal medical therapy, and the results of
enter the model when physician global estimate of risk is
physician’s estimate of the likelihood the patient will haveat L
are*
n Glo
Risk
CI
.93
0.24
.52
orbid
er the
s not
in theace, which could have allowed a systematically biased
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May 16, 2006:2034–41 Coronary Anatomy and Racenterpretation of the diagnostic studies. Future studies could
onsider blinded interpretation of the original clinical ma-
erial. It is also possible that clinicians could have tailored
heir estimates of the likelihood of coronary obstruction to
ustify the actions that they took. However, the clinician
urvey did not ask the physician to identify race, and race
as not mentioned in informed consent documents.
We also note that there was significant variation among
ites in the frequency with which coronary angiograms were
erformed, as well as the proportion of persons who had
ignificant coronary obstructions. Because we studied actual
linical practice, it is not surprising that the threshold for
oronary angiography, and thus the prevalence of coronary
bstruction, would vary among sites (32,33). Variation in
maging techniques and variability in the threshold for
alling a study positive may have also contributed to
ariations among sites. Our analytic technique allowed us to
ompare the results in AA and whites, adjusting for any site
ffect. Moreover, we believe that this study of actual clinical
ractice is an important approach to studying the racial
ifferences in care that have been described in practice. That
aid, we believe that studies applying standardized protocols
o well-characterized populations of diverse ethnicity are
lso important, because the interpretation of studies of
ctual practice are frequently affected by differences in
ractice such as those we observed.
Fourth, although our clinical data included patient symp-
oms, demographic characteristics, history of CAD, and a
hysician estimate of the likelihood of coronary disease for
ach patient, it is possible that additional clinical data would
dentify differences for which we did not account, but which
ould explain the discrepancy. However, our team of
xperienced clinicians and review of the literature did not
dentify other such important data elements. Further, we
xpect that the physician global estimates of risk would have
ncorporated any such information. Related to this, we ac-
nowledge that our use of a simple, readily reproducible
ethod for classifying the results of the nuclear imaging
tudy is likely less predictive of coronary outcomes than
ore complex scoring systems (25). This emphasizes that
lthough the present study demonstrates that AA may have
ess obstructive coronary disease than apparently clinically
imilar whites, it is still true that AA are more likely than
hites to die of ischemic heart disease, even adjusting for
oronary anatomy (12,34).
Finally, although the difference in coronary obstructive
isease prevalence by race is statistically significant, confi-
ence intervals are wide because of the relatively small
umber of AA patients included in the study. That is,
lthough the point estimates of the influence of race on
revalence are clinically important, the small sample size
recludes a very precise estimate of their magnitude. More-
ver, the fact that the study population was drawn from
epartment of Veterans Affairs hospitals resulted in anntirely male study population. Clearly, future studies ihould include larger numbers of patients, particularly
omen and AA.
As a group, our studies, and the studies cited above,
uggest that AA with clinical CAD have fewer obstructive
esions than whites with similar clinical findings. These
tudies are also consistent with the possibility that AA are
ust as likely to have CAD as whites, but physicians are less
ble to select the AA patients who have the obstructive
isease. However, we found that physician-estimated risk of
AD was as good a predictor of CAD in AA as it was in
hite patients. We note that previous reports of the oper-
ting characteristics of nuclear imaging studies typically
ave not examined whether sensitivity and specificity of
hese studies varies by patient race, although age and gender
o appear to affect tests for ischemia (27,35). Moreover,
tudies have shown that electrocardiogram criteria for left
entricular hypertrophy are less accurate among AA than
hey are among whites (36). Thus, we believe that studies of
he operating characteristics of diagnostic tests in diverse
opulations are needed.
Together with studies suggesting that AA are more likely
o die from coronary disease (34), these data suggest there are
mportant differences in the clinical manifestations of CAD
mong AA and whites. This disconnect between coronary
natomy and cardiovascular disease mortality is perhaps not
urprising, because epicardial vessel stenosis is a far-from-
erfect predictor of adverse outcomes (27,37). Improved
nderstanding of the diversity of factors influencing coro-
ary events may allow for better understanding of this
isconnect (38). There is some evidence that the construct
nown as race, although clearly a social and not scientific
onstruct (39), does identify groups with differing responses
o some therapies (40,41). Research focused on mechanisms
f disease may allow better understanding of racial differ-
nces by decreasing reliance on “race” as a surrogate for
roups of patients with important clinical differences in the
ehavior of cardiovascular disease.
How should these results affect the interpretation of the
umerous studies demonstrating racial disparities in use of
ngiography? For example, in this same study cohort, we
ave previously reported what we termed “disparate” use of
ngiography, which was not explained by patient demo-
raphics (except race), clinical characteristics, patient be-
iefs, or physician perceptions of patients’ personal charac-
eristics, but was associated with physicians’ gestalt clinical
ssessments of patients (e.g., ratings of the patient’s proba-
ility of CAD and the importance of angiography). The
ndings in the present analysis suggest that the physicians’
linical assessments of the likelihood of CAD, and the
enefit of coronary angiography, which varied by race in the
verall CDMS cohort, may have led to appropriately lower
se of coronary angiography among AA. This is not to say
hat the enormous literature demonstrating racial differences
n cardiac procedure use simply reflects unmeasured clinical
ifferences. However, it does emphasize the difficulty of
nterpreting such differences in real world settings. In
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Coronary Anatomy and Race May 16, 2006:2034–41articular, it emphasizes that focusing entirely on how
oronary stenoses are treated likely will not address the
roblem (or at least much of the problem) of racial differ-
nces in coronary disease outcomes.
In summary, we have demonstrated that AA were less
ikely to have obstructive coronary disease in a population of
atients whose clinical presentation caused them to undergo
uclear perfusion imaging and who had an imaging result
hat suggested reversible ischemia. We believe that these
ata call for increased efforts to better understand the best
iagnostic and therapeutic approach to the management of
AD in the AA population. It may be more important for
uture research to clarify the most appropriate approach to
anaging CAD in different populations than to focus solely
n racial differences in patterns of utilization of invasive
rocedures. Continuing the latter would give the implicit
essage that comparing rates of procedure use is the key
easure of whether AA and white patients receive equally
igh-quality care for CAD. These results suggest that the
ssue is more complicated.
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